IL6 and acute pancreatitis: The combined involvement of IL-6 and Ang-2 reflects inflammatory and endothelial processes that occur early during acute pancreatitis and are involved in the progression toward severe disease, providing a biological rationale for their evaluation as prognostic biomarkers in severe acute pancreatitis (Figure 1) [10].